Abbott (NYSE: ABT) reported Q1 EPS of $1.15, in-line with the analyst estimate of $1.15. Revenue for the quarter came in at $11.16 billion versus the consensus estimate of $11 billion.

GUIDANCE:

Abbott sees Q2 2026 EPS of $1.25-$1.31, versus the consensus of $1.32.

Abbott sees FY2026 EPS of $5.38-$5.58, versus the consensus of $5.47.

For earnings history and earnings-related data on Abbott (ABT) click here.